Bladder Cancer

• FDA label_change · 2025-01-03
  FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for doxorubicin hydrochloride from Zydus Lifesciences Limited, updating the labeling for the product…

• FDA label_change · 2018-02-15
  FDA Approved: CYSVIEW — Supplemental Application (Photocure Inc.)

  FDA approved a supplemental application for CYSVIEW to update its labeling (hexaminolevulinate hydrochloride) for use in the detection of bl…